Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017

Autor: B, Hampel, K, Kusejko, R D, Kouyos, J, Böni, M, Flepp, M, Stöckle, A, Conen, C, Béguelin, P, Künzler-Heule, D, Nicca, A J, Schmidt, H, Nguyen, J, Delaloye, M, Rougemont, E, Bernasconi, A, Rauch, H F, Günthard, D L, Braun, J, Fehr, S, Yerly

Publikováno v: HIV medicineReferences. 21(4)

OBJECTIVES Chemsex refers to the use of sex-enhancing drugs among men who have sex with men (MSM) in combination with specific sexual and social behaviours. Longitudinal data on this development and the associated health risks are scarce. METHODS Dat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2221820094096db32b1bea225b0d04d3
https://pubmed.ncbi.nlm.nih.gov/31849182

Predicting goal probabilities with improved xG models using event sequences in association football.

Autor: Bandara, Ishara^1,2 (AUTHOR) isharabnd@gmail.com, Shelyag, Sergiy^1,3 (AUTHOR), Rajasegarar, Sutharshan¹ (AUTHOR), Dwyer, Dan⁴ (AUTHOR), Kim, Eun-jin² (AUTHOR), Angelova, Maia^1,5,6 (AUTHOR)

Publikováno v: PLoS ONE. 10/30/2024, Vol. 19 Issue 10, p1-22. 22p.

Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection: meta-analyses of the randomised e vidence

Autor: A Gringeri, P Hartigan, R D'Aquila, J Yeo, L Dee, A Maeland, F Rousseau, J Darbyshire, M Flepp, T Merigan, H Chang, J Chodakewitz, C Farthing, K Stanley, G Van Weverling, L Mathiesen, R DeMasi, P Slade, H Melander, C Pettinelli, A Poppa, C Carbon, D Smith, M Seligmann, G Stingl, C Tierney, M Hughes, I Chalmers, M Foulkes, D Katzenstein, B Gazzard, L Struthers, Soriano, K Henry, J Veenstra, I Weller, S Danner, M Sande, L Deyton, E Sandstrom, M Fischl, A Phillips, D Richman, C Katlama, M Gartland, J Neaton, E King, A Collier, P Gotzsche, P Stoffels, G Rutherford, R Van der Broeck, D Allan, R Peto, J Rooney, J Ioannidis, W Duncan, F Antunes, S Schnittman, N Clendenin, J Lange, D Dixon, SK de Loes, A Babiker, E Cooper, D Hall, J Killen, P Volberding, A Hill, H McDade, A Meibohn, G Savidge, L Saravolatz, J Bruun, W Cameron, L Perrin, A Pinching, N Clumeck, M Simberkoff, P Mannucci, J Gatell, T Peto, M Heath-Chiozzi, M Salgo, G Skowron, R Van Leeuven, L Power, S Vella, J Phair, P Reiss, J Kahn, DeGruttola, D Winslow, M Myers, R Schooley, B Hirschel, S Hammer, R Leavitt, S Walker, G Collins, R Collins, J Leonard, RP Smith, D Abrams, J Mulder, J Hamilton, M Thompson, M Nessling, S Kravcik, Hiv Trialists' Collaborative Grp, D Cooper, A Breckenridge, F Goebel, J Dormont, J Weber, P Yeni, J Feinberg

Publikováno v: The Lancet. 353:2014-2025

Summary Background To assess the effects of zidovudine, didanosine, and zalcitabine on HIV disease progression and survival, we undertook meta-analyses of individual patient data and tabular data from all randomised trials that compared these agents.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9973fab0ba3628e3974bd59a2556e5f1
https://doi.org/10.1016/s0140-6736(98)12263-8

Mycobacterium tuberculosis Transmission in a Country with Low Tuberculosis Incidence: Role of Immigration and HIV Infection

Autor: Lukas Fenner, Sebastien Gagneux, Peter Helbling, Manuel Battegay, Hans L. Rieder, Gaby E. Pfyffer, Marcel Zwahlen, Hansjakob Furrer, Hans H. Siegrist, Jan Fehr, Marisa Dolina, Alexandra Calmy, David Stucki, Katia Jaton, Jean-Paul Janssens, Jesica Mazza Stalder, Thomas Bodmer, Beatrice Ninet, Erik C. Böttger, Matthias Egger, J. Barth, M. Battegay, E. Bernasconi, J. Böni, H. C. Bucher, A. Calmy Burton-Jeangros, M. Cavassini, C. Cellerai, M. Egger, L. Elzi, J. Fehr, J. Fellay, M. Flepp, P. Francioli, H. Furrer, C. A. Fux, M. Gorgievski, H. Günthard, D. Haerry, B. Hasse, B. Hirschel, H. H. Hirsch, M. Hoffmann, I. Hösli, C. Kahlert, L. Kaiser, O. Kaiser, C. Kind, T. Klimkait, H. Kovari, B. Ledergerber, A. P. Lugano, G. Martinetti, B. Martinez de Tejada, K. Metzner, N. Müller, D. Nadal, G. Pantaleo, A. Rauch, S. Regenass, M. Rickenbach, C. Rudin, P. Schmid, D. Schultze, F. Schöni-Affolter, J. Schüpbach, R. Speck, P. Taffé, P. Tarr, A. Telenti, A. Trkola, P. Vernazza, R. Weber, S. Yerly

Publikováno v: Journal of Clinical Microbiology, Vol. 50, No 2 (2012) pp. 388-95
Journal of clinical microbiology
Journal of Clinical Microbiology

Immigrants from high-burden countries and HIV-coinfected individuals are risk groups for tuberculosis (TB) in countries with low TB incidence. Therefore, we studied their role in transmission of Mycobacterium tuberculosis in Switzerland. We included

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fec1744f88fdc120c398b63c4c202a24
https://europepmc.org/articles/PMC3264153/